Berapa harga FluoroPharma Medical, Inc. (FPMI)

Harga FluoroPharma Medical, Inc. (FPMI) adalah $0.0002

Apa kapitalisasi pasar FluoroPharma Medical, Inc. (FPMI)

Kapitalisasi pasar FluoroPharma Medical, Inc. (FPMI) adalah $6.85K

FluoroPharma Medical, Inc. (FPMI) Imbal Hasil Dividen

FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.

Tahun	Hasil Dividen	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Hasil Dividen

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Hasil Dividen	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
UCB S.A. UCB.BR	0.65%	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR

Perusahaan

Hasil Dividen

Negara